Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel G Morgan

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Ebiomedicine|February 19, 2025
Targeting B-cell subsets in type 1 diabetes: possible routes to therapy?Noel G Morgan
Current Opinion in Clinical Nutrition and Metabolic Care|February 10, 2009
Fatty acids and beta-cell toxicityNoel G Morgan
European Journal of Endocrinology|January 17, 2024
Insulitis in human type 1 diabetes: lessons from an enigmatic lesionNoel G Morgan
British Journal of Pharmacology|December 8, 2010
Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cellsShalinee Dhayal, Noel G Morgan
Drug News & Perspectives|September 24, 2010
The significance of GPR119 agonists as a future treatment for type 2 diabetesShalinee Dhayal, Noel G Morgan
Frontiers in Endocrinology|March 15, 2021
Footprints of Immune Cells in the Pancreas in Type 1 Diabetes; to "B" or Not to "B": Is That Still the Question?Pia Leete, Noel G Morgan
FEBS Letters|June 2, 2011
Structure-activity relationships influencing lipid-induced changes in eIF2α phosphorylation and cell viability in BRIN-BD11 cellsShalinee Dhayal, Noel G Morgan
Biochemical Pharmacology|August 8, 2009
G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cellNoel G Morgan, Shalinee Dhayal
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 9, 2010
Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cellNoel G Morgan, Shalinee Dhayal
Biochemical Pharmacology|April 5, 2002
GTP-binding proteins in cell survival and demise: the emerging picture in the pancreatic beta-cellAnjaneyulu Kowluru, Noel G Morgan
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Ebiomedicine|February 19, 2025
Targeting B-cell subsets in type 1 diabetes: possible routes to therapy?Noel G Morgan
Current Opinion in Clinical Nutrition and Metabolic Care|February 10, 2009
Fatty acids and beta-cell toxicityNoel G Morgan
European Journal of Endocrinology|January 17, 2024
Insulitis in human type 1 diabetes: lessons from an enigmatic lesionNoel G Morgan
British Journal of Pharmacology|December 8, 2010
Pharmacological characterization of the cytoprotective effects of polyunsaturated fatty acids in insulin-secreting BRIN-BD11 cellsShalinee Dhayal, Noel G Morgan
Drug News & Perspectives|September 24, 2010
The significance of GPR119 agonists as a future treatment for type 2 diabetesShalinee Dhayal, Noel G Morgan
Frontiers in Endocrinology|March 15, 2021
Footprints of Immune Cells in the Pancreas in Type 1 Diabetes; to "B" or Not to "B": Is That Still the Question?Pia Leete, Noel G Morgan
FEBS Letters|June 2, 2011
Structure-activity relationships influencing lipid-induced changes in eIF2α phosphorylation and cell viability in BRIN-BD11 cellsShalinee Dhayal, Noel G Morgan
Biochemical Pharmacology|August 8, 2009
G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cellNoel G Morgan, Shalinee Dhayal
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 9, 2010
Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cellNoel G Morgan, Shalinee Dhayal
Biochemical Pharmacology|April 5, 2002
GTP-binding proteins in cell survival and demise: the emerging picture in the pancreatic beta-cellAnjaneyulu Kowluru, Noel G Morgan
Pageof 13